Decellularized xenografts in regenerative medicine: From processing to clinical application.

2021 
Decellularized xenografts are an inherent component of regenerative medicine. Their preserved structure, mechanical integrity and biofunctional composition have well established them in reparative medicine for a diverse range of clinical indications. Nonetheless, their performance is highly influenced by their source (ie species, age, tissue) and processing (ie decellularization, crosslinking, sterilization and preservation), which govern their final characteristics and determine their success or failure for a specific clinical target. In this review, we provide an overview of the different sources and processing methods used in decellularized xenografts fabrication and discuss their effect on the clinical performance of commercially available decellularized xenografts.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    391
    References
    0
    Citations
    NaN
    KQI
    []